Literature DB >> 6112632

Oral lorazepam to improve tolerance of cytotoxic therapy.

M Friedlander, J H Kearsley, M H Tattersall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6112632     DOI： 10.1016/s0140-6736(81)92489-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Antiemetic activity of high-dose methylprednisolone associated with continuous-infusion metoclopramide and oral alprazolam during multiple-day chemotherapy.

Authors:  G Salles; E Archimbaud; X Thomas; D Fiere
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 2.  Anaesthesia and emesis. II: Prevention and management.

Authors:  M G Palazzo; L Strunin
Journal:  Can Anaesth Soc J       Date:  1984-07

Review 3.  Anaesthetic premedication: aims, assessment and methods.

Authors:  T H Madej; R T Paasuke
Journal:  Can J Anaesth       Date:  1987-05       Impact factor: 5.063

4.  Alleviation of chemotherapy induced emesis by oral lorazepam and domperidone.

Authors:  P Warde; B Cantwell; J Fennelly; W Powderly; R Conroy
Journal:  Ir J Med Sci       Date:  1983-09       Impact factor: 1.568
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.